Intech Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	50.39	16.8	198.65	77.73	64.82	220.48
Short-Term Investments	142.5	197.5	60	520	310	115
Cash & Short-Term Investments	192.89	214.3	258.65	597.73	374.82	335.48
Cash Growth	-6.90%	-17.15%	-56.73%	59.47%	11.73%	10.11%
Accounts Receivable	12.4	4.38	9.28	3.05	3.67	15.04
Other Receivables	10.2	2.59	9.83	8.7	7.94	7.94
Receivables	22.6	6.97	19.11	11.74	11.6	22.98
Inventory	104.26	116.48	63.86	41.53	51.82	59.87
Prepaid Expenses	75.56	65.38	68.65	43.62	40.7	33.74
Other Current Assets	0.3	-	0.06	0.41	0.13	4.26
Total Current Assets	395.6	403.13	410.32	695.02	479.06	456.33
Property, Plant & Equipment	1,390	1,403	1,885	1,900	2,009	2,090
Other Intangible Assets	4.56	4.89	3.86	4.88	4.8	4.62
Long-Term Deferred Tax Assets	24.77	24.77	24.77	24.77	24.77	24.77
Other Long-Term Assets	512.46	514.69	71.69	86.15	33.17	26.26
Total Assets	2,328	2,351	2,396	2,711	2,551	2,602
Accounts Payable	11.67	3.9	9.82	0.31	1.33	2.4
Accrued Expenses	-	26.44	28.82	19.24	23.71	20.82
Short-Term Debt	80	-	-	-	-	-
Current Portion of Long-Term Debt	-	192.73	248.82	464.65	265.26	211.66
Current Portion of Leases	0.39	0.39	-	-	-	-
Current Unearned Revenue	12.94	12.94	81.18	78.54	78.31	78.99
Other Current Liabilities	306.2	6.92	18	5.99	5.23	9.35
Total Current Liabilities	411.2	243.32	386.64	568.73	373.82	323.22
Long-Term Debt	912.54	994.9	1,188	970.41	1,143	940.77
Long-Term Leases	0.51	0.6	-	-	-	-
Long-Term Unearned Revenue	8.84	8.84	5.53	2.35	-	-
Pension & Post-Retirement Benefits	-	0.85	-	-	-	-
Long-Term Deferred Tax Liabilities	0.02	0.02	-	-	-	-
Other Long-Term Liabilities	2.78	1.45	1.72	1.74	1.54	-
Total Liabilities	1,336	1,250	1,582	1,543	1,519	1,264
Common Stock	1,784	1,784	1,379	1,374	1,170	1,163
Additional Paid-In Capital	282.41	282.09	19.76	286.16	195.15	481.32
Retained Earnings	-1,071	-959.57	-579.76	-488.08	-327.88	-301.76
Comprehensive Income & Other	-2.86	-5.58	-5.16	-4.32	-5.13	-4.72
Shareholders' Equity	991.64	1,101	814.28	1,168	1,032	1,338
Total Liabilities & Equity	2,328	2,351	2,396	2,711	2,551	2,602
Total Debt	993.44	1,189	1,436	1,435	1,409	1,152
Net Cash (Debt)	-800.55	-974.31	-1,178	-837.33	-1,034	-816.94
Net Cash Per Share	-4.49	-6.42	-8.58	-6.95	-8.90	-8.03
Filing Date Shares Outstanding	178.41	178.41	137.94	137.41	116.96	116.28
Total Common Shares Outstanding	178.41	178.41	137.94	137.41	116.96	116.28
Working Capital	-15.6	159.81	23.68	126.3	105.24	133.11
Book Value Per Share	5.56	6.17	5.90	8.50	8.82	11.50
Tangible Book Value	987.08	1,096	810.42	1,163	1,027	1,333
Tangible Book Value Per Share	5.53	6.14	5.87	8.46	8.78	11.46
Land	-	516.45	919.87	919.87	950.72	950.72
Buildings	-	756.97	791.07	790.24	798.32	810.2
Machinery	-	754.83	724.87	657.12	645.9	633.52